InvestorsHub Logo
Followers 0
Posts 22925
Boards Moderated 1
Alias Born 10/28/2010

Re: 1~Eye~Jack!! post# 5453

Thursday, 11/20/2014 10:10:47 PM

Thursday, November 20, 2014 10:10:47 PM

Post# of 118423
~ RGBP = Regen's dCellVax therapy is based on US Patent # 8,389,708, acquired from Professor Wei-Ping Min at the University of Western Ontario, Canada, as well as a collaboration between Dr. Min and the Company's Chief Science Officer Dr. Thomas Ichim. Preclinical studies have demonstrated efficacy in mouse models of breast cancer and melanoma. wink